Recently Released Market Study: Generics: US Regulatory Update
The US regulatory environment for generic drugs evolved in a number of ways over 2011 and early 2012. Both the Senate and the House of Representatives passed bills that would implement generic user fees as part of wider Prescription Drug User Fee Act (PDUFA) re-authorization. An agreement must still be reached regarding differences between the bills before being signed by President Obama.
View full press release